For those operating in the life sciences sector, it’s all too clear that the time has come for 2024 industry predictions. In ...

Eleven new digital health start-ups have graduated from PharmStars’ twice-yearly education and mentoring programme, with the ...

Regeneron is playing catch-up in the BCMAxCD3 class with Johnson & Johnson’s Tecvayli (teclistamab) and Pfizer’s Elrexfio ...

Historically, the pharmaceutical industry has been slow to adopt digital business models. This is because the industry is ...

The PrEPVacc trial in East and Sothern Africa is currently the only large-scale HIV vaccine efficacy trial being conducted in ...

At the start of this year, Aeglea BioTherapeutics was looking like it may go out of business. Now, rebranded as Spyre ...

Which is why I say well done, Pfizer! I was delighted to read the recent news from Pfizer announcing the launch of their ...

Accelerate Next Generation RNAs into Safe & Effective Clinical Candidates with Therapeutic Potentials Across All Diseases by Overcoming Quality, Stability, & Large-Scale Manufacturing Hurdles ...

Enhance Speed, Purity & Scalability of Your Process Development & Manufacturing to Improve Functionality, Efficacy & Approval Rate of mRNA Drugs Across All Disease Indication Returning to Frankfurt, ...

Germany’s Merck KGaA is facing a big hole in its late-stage pipeline after multiple sclerosis (MS) candidate evobrutinib ...

A field that’s poorly defined and understood, women’s health is a social, a cultural, even a political issue. It doesn’t need ...

Genomic technology company Biofidelity has announced the launch of ASPYRE-Lung reagents (RUO) for research use, marking its ...